Wadud Z, Chintakayala P. Personal carbon trading: trade-off and complementarity between in-home and transport related emissions reduction. Ecol Econ. 2019 Feb;156:397-408. doi: 10.1016/j.ecolecon.2018.10.016
Van Houtven G, Mansfield C, Phaneuf DJ, von Haefen R, Milstead B, Kenney MA, Reckhow KH. Combining expert elicitation and stated-preference methods to value ecosystem services from improved lake water quality. Ecol Econ. 2014 Mar;99:40-52. doi: 10.1016/j.ecolecon.2013.12.018.
Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolanos-Meade J, Brown JMY, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR. Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. Am J Health Syst Pharm. 2013 Sep;70(17):1518-27.
Bristow AL, Wardman M, Zanni AM, Chintakayala PK. Public acceptability of personal carbon trading and carbon tax. Ecol Econ. 2010 Jul 15;69(9):1824-37. doi: 10.1016/j.ecolecon.2010.04.021
Menzin J, Meyers JL, Friedman M, Perfect JR, Langston AA, Danna RP, Papadopoulos G. Mortality, length of hospitalization, and costs associated with invasive fungal infections in high risk patients. Am J Health Syst Pharm. 2009 Oct;66(19):1711-7. doi: 10.2146/ajhp080325.
Talbird SE, Brogan AJ, Winiarski AP, Sander B. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. Am J Health Syst Pharm. 2009 Mar 1;66(5):469-80.